Ryan Pelletier

5PUBLICATIONS
9CO-AUTHORS
Epidemiological methodsToxicology (incl. clinical toxicology)Predictive and prognostic markersPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 12, 2025
Unpacking Oral Challenge Protocols: A Descriptive Epidemiologic Study of Reactions, Predictors, and Practices for Delabeling Low-Risk Penicillin Allergies Leveraging Data from a Systematic Review and Meta-Analysis.

Mira Maximos, Ryan Pelletier, Sameer Elsayed

|Mar 05, 2022
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.

Wajd Alkabbani, Ryan Pelletier, Michael A Beazely

|Mar 24, 2021
Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.

Ryan Pelletier

|Feb 08, 2021
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews.

Ryan Pelletier, Kelvin Ng, Wajd Alkabbani

|Jul 25, 2020
The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews.

Ryan Pelletier, Kelvin Ng, Wajd Alkabbani

Pageof 1

Frequent Collaborators

3 joint publications

John-Michael Gamble

2 joint publications

Wajd Alkabbani

1 joint publications

Kelvin Ng

1 joint publications

Michael A Beazely